Home
>
National Drug Code (NDC)
>
Opahl
Opahl - 53045-103-30 - (Benzocaine)
Drug Information of Opahl
| Product NDC: | 53045-103 |
| Proprietary Name: | Opahl |
| Non Proprietary Name: | Benzocaine |
| Active Ingredient(s): | 6.4 g/32g & nbsp; Benzocaine |
| Administration Route(s): | DENTAL; ORAL; TOPICAL |
| Dosage Form(s): | GEL |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Opahl
| Product NDC: | 53045-103 |
| Labeler Name: | Dharma Research, inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Start Marketing Date: | 20130101 |
Package Information of Opahl
| Package NDC: | 53045-103-30 |
| Package Description: | 32 g in 1 BOTTLE (53045-103-30) |
NDC Information of Opahl
| NDC Code | 53045-103-30 |
| Proprietary Name | Opahl |
| Package Description | 32 g in 1 BOTTLE (53045-103-30) |
| Product NDC | 53045-103 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Benzocaine |
| Dosage Form Name | GEL |
| Route Name | DENTAL; ORAL; TOPICAL |
| Start Marketing Date | 20130101 |
| Marketing Category Name | UNAPPROVED DRUG OTHER |
| Labeler Name | Dharma Research, inc. |
| Substance Name | BENZOCAINE |
| Strength Number | 6.4 |
| Strength Unit | g/32g |
| Pharmaceutical Classes | Standardized Chemical Allergen [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [Chemical/Ingredient] |
